Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 308976, 10 pages
http://dx.doi.org/10.1155/2014/308976
Review Article

Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer Development

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, 1 University Road, Tainan 701, Taiwan

Received 29 June 2013; Revised 31 October 2013; Accepted 1 November 2013; Published 23 January 2014

Academic Editor: Robert Pichler

Copyright © 2014 Chi-Yun Wang and Chiou-Feng Lin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Hajjar and S. Krishnan, “Annexin II: a mediator of the plasmin/plasminogen activator system,” Trends in Cardiovascular Medicine, vol. 9, no. 5, pp. 128–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Huebner, L. A. Cannizzaro, A. L. Frey et al., “Chromosomal localization of the human genes for lipocortin I and lipocortin II,” Oncogene Research, vol. 2, no. 4, pp. 299–310, 1988. View at Google Scholar · View at Scopus
  3. K. A. Hajjar, L. Mauri, A. T. Jacovina et al., “Tissue plasminogen activator binding to the annexin II tail domain: direct modulation by homocysteine,” Journal of Biological Chemistry, vol. 273, no. 16, pp. 9987–9993, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Johnsson, G. Marriott, and K. Weber, “p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix,” The EMBO Journal, vol. 7, no. 8, pp. 2435–2442, 1988. View at Google Scholar · View at Scopus
  5. S. E. Moss and R. O. Morgan, “The annexins,” Genome Biology, vol. 5, no. 4, article f219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Filipenko and D. M. Waisman, “The C terminus of annexin II mediates binding to F-actin,” Journal of Biological Chemistry, vol. 276, no. 7, pp. 5310–5315, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Kassam, A. Manro, C. E. Braat, P. Louie, S. L. Fitzpatrick, and D. M. Waisman, “Characterization of the heparin binding properties of annexin II tetramer,” Journal of Biological Chemistry, vol. 272, no. 24, pp. 15093–15100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Hajjar, A. T. Jacovina, and J. Chacko, “An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II,” Journal of Biological Chemistry, vol. 269, no. 33, pp. 21191–21197, 1994. View at Google Scholar · View at Scopus
  9. C. Thiel, M. Osborn, and V. Gerke, “The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca2+-binding sites,” Journal of Cell Science, vol. 103, no. 3, pp. 733–742, 1992. View at Google Scholar · View at Scopus
  10. A. B. Deora, G. Kreitzer, A. T. Jacovina, and K. A. Hajjar, “An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface,” Journal of Biological Chemistry, vol. 279, no. 42, pp. 43411–43418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Sarafian, L.-A. Pradel, J.-P. Henry, D. Aunis, and M.-F. Bader, “The participation of annexin II (Calpactin I) in calcium-evoked exocytosis requires protein kinase C,” Journal of Cell Biology, vol. 114, no. 6, pp. 1135–1147, 1991. View at Google Scholar · View at Scopus
  12. N. Emans, J.-P. Gorvel, C. Walter et al., “Annexin II is a major component of fusogenic endosomal vesicles,” Journal of Cell Biology, vol. 120, no. 6, pp. 1357–1369, 1993. View at Google Scholar · View at Scopus
  13. E. Morel and J. Gruenberg, “The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport,” PLoS ONE, vol. 2, no. 10, Article ID e1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. B. Babiychuk and A. Draeger, “Annexins in cell membrane dynamics: Ca2+-regulated association of lipid microdomains,” Journal of Cell Biology, vol. 150, no. 5, pp. 1113–1124, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Chiang, A. Rizzino, Z. A. Sibenaller, M. S. Wold, and J. K. Vishwanatha, “Specific down-regulation of annexin II expression in human cells interferes with cell proliferation,” Molecular and Cellular Biochemistry, vol. 199, no. 1-2, pp. 139–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Johnstone, I. Hubaishy, and D. M. Waisman, “Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein,” Journal of Biological Chemistry, vol. 267, no. 36, pp. 25976–25981, 1992. View at Google Scholar · View at Scopus
  17. S. Oliferenko, K. Paiha, T. Harder et al., “Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton,” Journal of Cell Biology, vol. 146, no. 4, pp. 843–854, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Martin, J. Leffler, and A. M. Blom, “Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells,” Journal of Biological Chemistry, vol. 287, pp. 33733–33744, 2012. View at Google Scholar
  19. Y. Huang, C.-H. Yan, and S.-B. Fu, “The cloning and expression of apoptosis associated gene ANNEXIN A2 induced by p53 gene,” Chinese Journal of Medical Genetics, vol. 22, no. 6, pp. 661–664, 2005. View at Google Scholar · View at Scopus
  20. K. M. Waters, D. L. Stenoien, M. B. Sowa et al., “Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate,” Radiation Research, vol. 179, pp. 53–61, 2013. View at Google Scholar
  21. P. A. Madureira, R. Hill, P. W. Lee, and D. M. Waisman, “Genotoxic agents promote the nuclear accumulation of annexin A2: role of annexin A2 in mitigating DNA damage,” PLoS ONE, vol. 7, Article ID e50591, 2012. View at Google Scholar
  22. P. A. Madureira, R. Hill, V. A. Miller, C. Giacomantonio, P. W. Lee, and D. M. Waisman, “Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis,” Oncotarget, vol. 2, no. 12, pp. 1075–1093, 2011. View at Google Scholar
  23. U. M. Halfter, Z. E. Derbyshire, and R. R. Vaillancourt, “Interferon-γ-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes,” Biochemical Journal, vol. 388, no. 1, pp. 17–28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Inokuchi, N. Narula, D. S. Yee et al., “Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells,” International Journal of Cancer, vol. 124, no. 1, pp. 68–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Tsukamoto, S. Tanida, K. Ozeki et al., “Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-alpha in monocytes and colon epithelial cells,” Inflammatory Bowel Diseases, vol. 19, pp. 1365–1373, 2013. View at Google Scholar
  26. C. Comera, B. Rothhut, and F. Russo-Marie, “Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells,” European Journal of Biochemistry, vol. 188, no. 1, pp. 139–146, 1990. View at Google Scholar · View at Scopus
  27. X. Fan, S. Krahling, D. Smith, P. Williamson, and R. A. Schlegel, “Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes,” Molecular Biology of the Cell, vol. 15, no. 6, pp. 2863–2872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-S. Choi, S. L. Fitzpatrick, N. R. Filipenko et al., “Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer,” Journal of Biological Chemistry, vol. 276, no. 27, pp. 25212–25221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Ling, A. T. Jacovina, A. Deora et al., “Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo,” Journal of Clinical Investigation, vol. 113, no. 1, pp. 38–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Mai, R. L. Finley Jr., D. M. Waisman, and B. F. Sloane, “Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells,” Journal of Biological Chemistry, vol. 275, no. 17, pp. 12806–12812, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. M. R. Sharma, V. Rothman, G. P. Tuszynski, and M. C. Sharma, “Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action,” Experimental and Molecular Pathology, vol. 81, no. 2, pp. 136–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Huang, A. B. Deora, K.-L. He et al., “Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice,” Blood, vol. 118, no. 10, pp. 2918–2929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. A. Swisher, N. Burton, S. M. Bacot, S. N. Vogel, and G. M. Feldman, “Annexin A2 tetramer activates human and murine macrophages through TLR4,” Blood, vol. 115, no. 3, pp. 549–558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. F. A. Swisher, U. Khatri, and G. M. Feldman, “Annexin A2 is a soluble mediator of macrophage activation,” Journal of Leukocyte Biology, vol. 82, no. 5, pp. 1174–1184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Zhang, W. Yan, M. A. Collins et al., “Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance,” Cancer Research, 2013. View at Publisher · View at Google Scholar
  36. W. Ohishi, J. B. Cologne, S. Fujiwara et al., “Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study,” International Journal of Cancer, vol. 134, pp. 154–163, 2014. View at Google Scholar
  37. M. Strioga, V. Schijns, D. J. Powell Jr., V. Pasukoniene, N. Dobrovolskiene, and J. Michalek, “Dendritic cells and their role in tumor immunosurveillance,” Innate Immunity, vol. 19, pp. 98–111, 2013. View at Google Scholar
  38. B. Scharf, C. C. Clement, X.-X. Wu et al., “Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris,” Nature Communications, vol. 3, article 755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. R. N. Apte and E. Voronov, “Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?” Immunological Reviews, vol. 222, no. 1, pp. 222–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Palma, A. Barbieri, S. Bimonte et al., “Interleukin 18: friend or foe in cancer,” Biochimica et Biophysica Acta, vol. 1836, pp. 482–487, 2013. View at Google Scholar
  41. F. M. Brichory, D. E. Misek, A.-M. Yim et al., “An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, pp. 9824–9829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Dubois, J.-P. Oudinet, F. Russo-Marie, and B. Rothhut, “In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V,” Biochemical Journal, vol. 310, no. 1, pp. 243–248, 1995. View at Google Scholar · View at Scopus
  43. I. Hubaishy, P. G. Jones, J. Bjorge et al., “Modulation of annexin II tetramer by tyrosine phosphorylation,” Biochemistry, vol. 34, no. 44, pp. 14527–14534, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Brandherm, J. Disse, D. Zeuschner, and V. Gerke, “cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2,” Blood, vol. 122, no. 6, pp. 1042–1051, 2013. View at Google Scholar
  45. W. H. Rowan III, P. Sun, and L. Liu, “Nitration of annexin II tetramer,” Biochemistry, vol. 41, no. 4, pp. 1409–1420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Nazmi, G. Ozorowski, M. Pejic, J. P. Whitelegge, V. Gerke, and H. Luecke, “N-terminal acetylation of annexin A2 is required for S100A10 binding,” Biological Chemistry, vol. 393, pp. 1141–1150, 2012. View at Google Scholar
  47. S. Deng, B. Jing, T. Xing, L. Hou, and Z. Yang, “Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer,” Genomics Proteomics Bioinformatics, vol. 10, no. 3, pp. 153–157, 2012. View at Google Scholar
  48. K.-L. He, A. B. Deora, H. Xiong et al., “Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11,” Journal of Biological Chemistry, vol. 283, no. 28, pp. 19192–19200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. B. Babiychuk, K. Monastyrskaya, F. C. Burkhard, S. Wray, and A. Draeger, “Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts,” FASEB Journal, vol. 16, no. 10, pp. 1177–1184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. A. M. Cuervo, A. V. Gomes, J. A. Barnes, and J. F. Dice, “Selective degradation of annexins by chaperone-mediated autophagy,” Journal of Biological Chemistry, vol. 275, no. 43, pp. 33329–33335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Kassam, B.-H. Le, K.-S. Choi et al., “The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation,” Biochemistry, vol. 37, no. 48, pp. 16958–16966, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Laumonnier, T. Syrovets, L. Burysek, and T. Simmet, “Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes,” Blood, vol. 107, no. 8, pp. 3342–3349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Matsunaga, T. Inaba, H. Matsui et al., “Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein,” Blood, vol. 103, no. 8, pp. 3185–3191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. C.-Y. Wang, Y.-S. Lin, W.-C. Su, C.-L. Chen, and C.-F. Lin, “Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis,” Molecular Biology of the Cell, vol. 20, no. 19, pp. 4153–4161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Zhang, B. Guo, Y. Zhang, J. Cao, and T. Chen, “Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion,” Saudi Medical Journal, vol. 31, no. 4, pp. 374–381, 2010. View at Google Scholar · View at Scopus
  56. T. Yamane, R. Hachisu, M. Yuguchi et al., “Knockdown of legumain inhibits cleavage of annexin A2 in the mouse kidney,” Biochemical and Biophysical Research Communications, vol. 430, pp. 482–487, 2013. View at Google Scholar
  57. J. A. Spijkers-Hagelstein, S. Mimoso Pinhancos, P. Schneider, R. Pieters, and R. W. Stam, “Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia,” Leukemia, vol. 27, pp. 1063–1071, 2013. View at Google Scholar
  58. J. S. Menell, G. M. Cesarman, A. T. Jacovina, M. A. McLaughlin, E. A. Lev, and K. A. Hajjar, “Annexin II and bleeding in acute promyelocytic leukemia,” The New England Journal of Medicine, vol. 340, no. 13, pp. 994–1004, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. M. R. Sharma, L. Koltowski, R. T. Ownbey, G. P. Tuszynski, and M. C. Sharma, “Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression,” Experimental and Molecular Pathology, vol. 81, no. 2, pp. 146–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Emoto, Y. Yamada, H. Sawada et al., “Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma,” Cancer, vol. 92, pp. 1419–1426, 2001. View at Google Scholar
  61. K. Emoto, H. Sawada, Y. Yamada et al., “Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma,” Anticancer Research, vol. 21, no. 2, pp. 1339–1346, 2001. View at Google Scholar · View at Scopus
  62. B. J. Roseman, A. Bollen, J. Hsu, K. Lamborn, and M. A. Israel, “Annexin II marks astrocytic brain tumors of high histologic grade,” Oncology Research, vol. 6, no. 12, pp. 561–567, 1994. View at Google Scholar · View at Scopus
  63. H. S. Mohammad, K. Kurokohchi, H. Yoneyama et al., “Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma,” International Journal of Oncology, vol. 33, no. 6, pp. 1157–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. W. Jia, K. L. Li, J. X. Wu, and S. L. Guo, “Clinical significance of annexin II expression in human non-small cell lung cancer,” Tumor Biology, vol. 34, pp. 1767–1771, 2013. View at Google Scholar
  65. C. Y. Wang, C. L. Chen, Y. L. Tseng et al., “Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms,” The Journal of Biological Chemistry, vol. 287, pp. 32512–32524, 2012. View at Google Scholar
  66. H. Bao, M. Jiang, M. Zhu, F. Sheng, J. Ruan, and C. Ruan, “Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma,” International Journal of Hematology, vol. 90, no. 2, pp. 177–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. J. P. Rodrigo, P. Lequerica-Fernández, P. Rosado, E. Allonca, J. M. García-Pedrero, and J. C. de Vicente, “Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma,” Head and Neck, vol. 33, no. 12, pp. 1708–1714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. I. Esposito, R. Penzel, M. Chaib-Harrireche et al., “Tenascin C and annexin II expression in the process of pancreatic carcinogenesis,” Journal of Pathology, vol. 208, no. 5, pp. 673–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. J. K. Vishwanatha, Y. Chiang, K. D. Kumble, M. A. Hollingsworth, and P. M. Pour, “Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers,” Carcinogenesis, vol. 14, no. 12, pp. 2575–2579, 1993. View at Google Scholar · View at Scopus
  70. Y. Liu, Z. Wang, M. Jiang et al., “The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia,” Leukemia Research, vol. 35, no. 7, pp. 879–884, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Zhang, H. Zhou, J. Wang et al., “Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator,” Thrombosis Research, vol. 106, no. 1, pp. 63–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Sharma, M. R. Blackman, and M. C. Sharma, “Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model,” Experimental and Molecular Pathology, vol. 92, no. 1, pp. 175–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Ding, L. Yang, Y. Wang, J. Yuan, T. Chen, and X. Cai, “Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis,” Molecular Medicine Reports, vol. 3, no. 5, pp. 781–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. P. K. Shetty, S. I. Thamake, S. Biswas, S. L. Johansson, and J. K. Vishwanatha, “Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer,” PLoS ONE, vol. 7, Article ID e44299, 2012. View at Google Scholar
  75. T. Yang, H. Peng, J. Wang et al., “Annexin A2 promotes glioma cell invasion and tumor progression,” Colorectal Disease, vol. 15, no. 7, pp. e373–e381, 2013. View at Google Scholar
  76. A. Guzmán-Aránguez, N. Olmo, J. Turnay et al., “Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5,” Journal of Cellular Biochemistry, vol. 94, no. 1, pp. 178–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Singh, H. Wu, C. Clark, and A. Owlia, “Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells,” Oncogene, vol. 26, no. 3, pp. 425–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. Q. Zhang, Z. Ye, Q. Yang, X. He, H. Wang, and Z. Zhao, “Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer,” World Journal of Surgical Oncology, vol. 10, article 103, 2012. View at Google Scholar
  79. H. Zhai, S. Acharya, I. Gravanis et al., “Annexin A2 promotes glioma cell invasion and tumor progression,” Journal of Neuroscience, vol. 31, no. 40, pp. 14346–14360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Tatenhorst, U. Rescher, V. Gerke, and W. Paulus, “Knockdown of annexin 2 decreases migration of human glioma cells in vitro,” Neuropathology and Applied Neurobiology, vol. 32, no. 3, pp. 271–277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Zhao, W. Zhang, J. Tang et al., “Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147,” Cancer Science, vol. 101, no. 2, pp. 387–395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Sun, G. Gao, J. Cai et al., “Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma,” Carcinogenesis, vol. 34, pp. 595–604, 2013. View at Google Scholar
  83. T. Longerich, M. T. Haller, C. Mogler et al., “Annexin A2 as a differential diagnostic marker of hepatocellular tumors,” Pathology Research and Practice, vol. 207, no. 1, pp. 8–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. C. Luk, M.-S. Tsao, J. Bayani, F. Shepherd, and J. A. Squire, “Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization,” Cancer Genetics and Cytogenetics, vol. 125, no. 2, pp. 87–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. S. P. Cole, M. J. Pinkoski, G. Bhardwaj et al., “Elevated expression of annexin II, (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line,” British Journal of Cancer, vol. 65, pp. 498–502, 1992. View at Google Scholar
  86. Y. X. Wang, H. Lv, Z. X. Li, C. Li, and X. Y. Wu, “Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549,” Pathology and Oncology Research, vol. 18, pp. 183–190, 2012. View at Google Scholar
  87. A. Seckinger, T. Meissner, J. Moreaux et al., “Clinical and prognostic role of annexin A2 in multiple myeloma,” Blood, vol. 120, pp. 1087–1094, 2012. View at Google Scholar
  88. V. M. Díaz, M. Hurtado, T. M. Thomson, J. Reventós, and R. Paciucci, “Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro,” Gut, vol. 53, no. 7, pp. 993–1000, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Zheng, K. Foley, L. Huang et al., “Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer,” PLoS ONE, vol. 6, no. 4, Article ID e19390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Nedjadi, N. Kitteringham, F. Campbell et al., “S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility,” British Journal of Cancer, vol. 101, no. 7, pp. 1145–1154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Chiang, R. G. Davis, and J. K. Vishwanatha, “Altered expression of annexin II in human B-cell lymphoma cell lines,” Biochimica et Biophysica Acta, vol. 1313, no. 3, pp. 295–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Ohno, M. Izumi, T. Kawamura, T. Nishimura, K. Mukai, and M. Tachibana, “Annexin II represents metastatic potential in clear-cell renal cell carcinoma,” British Journal of Cancer, vol. 101, no. 2, pp. 287–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. L.-P. Zhong, K.-J. Wei, X. Yang et al., “Increased expression of Annexin A2 in oral squamous cell carcinoma,” Archives of Oral Biology, vol. 54, no. 1, pp. 17–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. J.-G. Feng, Q. Liu, X. Qin et al., “Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas,” Molecular Biology Reports, vol. 39, no. 2, pp. 1267–1274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. X. Zhang, H.-Y. Zhi, J. Zhang et al., “Expression of annexin II in human esophageal squamous cell carcinoma,” Zhonghua zhong liu za zhi, vol. 25, no. 4, pp. 353–355, 2003. View at Google Scholar · View at Scopus
  96. J. M. Gillette, D. C. Chan, and S. M. Nielsen-Preiss, “Annexin 2 expression is reduced in human osteosarcoma metastases,” Journal of Cellular Biochemistry, vol. 92, no. 4, pp. 820–832, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. J.-W. Liu, J.-J. Shen, A. Tanzillo-Swarts et al., “Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration,” Oncogene, vol. 22, no. 10, pp. 1475–1485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Chetcuti, S. H. Margan, P. Russell et al., “Loss of Annexin II heavy and light chains in prostate cancer and its precursors,” Cancer Research, vol. 61, no. 17, pp. 6331–6334, 2001. View at Google Scholar · View at Scopus
  99. J. Liu, C. A. Rothermund, J. Ayala-Sanmartin, and J. K. Vishwanatha, “Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II,” BMC Biochemistry, vol. 4, article 1, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Shiozawa, A. M. Havens, Y. Jung et al., “Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer,” Journal of Cellular Biochemistry, vol. 105, no. 2, pp. 370–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. R. Paciucci, M. Torà, V. M. Díaz, and F. X. Real, “The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro,” Oncogene, vol. 16, no. 5, pp. 625–633, 1998. View at Google Scholar · View at Scopus
  102. K.-S. Choi, D. K. Fogg, C.-S. Yoon, and D. M. Waisman, “p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells,” FASEB Journal, vol. 17, no. 2, pp. 235–246, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. A. R. Braden, M. T. Kafka, L. Cunningham, H. Jones, and J. K. Vishwanatha, “Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth,” Journal of Nanoscience and Nanotechnology, vol. 9, no. 5, pp. 2856–2865, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. K. D. Kumble, P. L. Iversen, and J. K. Vishwanatha, “The role of primer recognition proteins in DNA replication: inhibition of cellular proliferation by antisense oligodeoxyribonucleotides,” Journal of Cell Science, vol. 101, no. 1, pp. 35–41, 1992. View at Google Scholar · View at Scopus
  105. J. K. Vishwanatha, H. K. Jindal, and R. G. Davis, “The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells,” Journal of Cell Science, vol. 101, no. 1, pp. 25–34, 1992. View at Google Scholar · View at Scopus
  106. J. K. Vishwanatha and S. Kumble, “Involvement of annexin II in DNA replication: evidence from cell-free extracts of Xenopus eggs,” Journal of Cell Science, vol. 105, no. 2, pp. 533–540, 1993. View at Google Scholar · View at Scopus
  107. L. Jin, Q. Shen, S. Ding, W. Jiang, L. Jiang, and X. Zhu, “Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy,” Gynecologic Oncology, vol. 126, pp. 140–146, 2012. View at Publisher · View at Google Scholar · View at Scopus